Explore the vast range of titles available.

Bovine viral diarrhoea virus (BVDV) is the causative agent of bovine viral diarrhoea/mucocutaneous disease (BVD-MD). Its associated co-infections pose a threat to the cattle industry, which is becoming a key breakthrough in the global system of prevention in the cattle industry. In recent years, cases of co-infection have occurred and been reported from time to time, and this situation not only poses certain difficulties in controlling the outbreak and in treatment in the farming industry, but also poses considerable challenges in detection and diagnosis. In this review, by systematically integrating studies on BVDV co-infection, we firstly compared and analysed the characteristics of BVDV co-infection with viruses, bacteria and other pathogens in in vivo/in vitro models in terms of synergism, host immune response and epidemiological transmission. Then we systematically constructed a BVDV Co-infection Impact Map, which demonstrates a paradigm of pathogen–host–immune interactions in the transmission of BVDV and provides a theoretical framework for breaking through the current precision diagnostic strategies and showcasing the effectiveness of integrated prevention and control.

Bovine viral diarrhoea (BVD) is one of the most economically damaging livestock enzootic diseases in the world. BVD aetiological agents are three pestiviruses (BVDV-1, -2 and HoBi-like pestivirus), which exhibit high genetic diversity and complex transmission cycles. This considerably hampers the management of the disease, which is why eradication plans have been implemented in several countries. In France, a national plan has been in place since 2019. Our understanding of its impact on the distribution of BVDV genotypes is limited by the availability of French genetic data. Here, we conducted a molecular epidemiology study to refine our knowledge of BVDV genetic diversity in France, characterise its international relationships, and analyse national spatio-temporal genotypic distribution. We collated 1037 BVDV-positive samples throughout France between 2011 and 2023, with a greater sampling effort in two major cattle production areas. We developed a high-throughput sequencing protocol which we used to complete the 5’UTR genotyping of this collection. We show that two main BVDV-1 genotypes, 1e and 1b, account for 88% of genotyped sequences. We also identified seven other BVDV-1 genotypes occurring at low frequencies and three BVDV-2 samples (genotype 2c). Phylogenetic analyses indicate different worldwide distribution patterns between the two main BVDV-1 genotypes. Their relative frequencies present no major changes in France since the 1990s and few variations at the national scale. We also found some degree of local spatial structuring in western France. Overall, our results demonstrate the potential of large-scale sequence-based surveillance to monitor changes in the epidemiological situation of enzootic diseases.

Bovine Viral Diarrhoea (BVD) is an infectious disease caused by the Bovine Viral Diarrhoea Virus (BVDV), a member of the genus . The disease remains endemic across Australian beef and dairy production systems, imposing a multi-million-dollar annual burden on animal health, welfare, and industry sustainability. BVDV can be transmitted both horizontally and vertically, with persistently infected (PI) animals serving as the primary source of infection. Rapid identification and subsequent culling of PI animals are fundamental requirements for any successful eradication program. Currently, Australia's decentralised, non-compulsory approach places the responsibility of biosecurity on individual producers, resulting in a fragmented national landscape. This review proposes that the strategic deployment of rapid, field-deployable point-of-care (POC) diagnostics serves as the transformative catalyst needed for a coordinated national eradication pathway. POC approaches utilising technologies such as lateral flow assays, nucleic acid amplification tests, and biosensors enable real-time, crush-side diagnosis and high-throughput surveillance, proving effective for early detection and control of infectious diseases. When integrated with robust biosecurity measures and optimised vaccination strategies, these POC advancements offer a scientifically sound and commercially viable pathway toward the systematic eradication of BVDV in the Australian cattle industry.

To determine the nationwide status of persistent BVDV infection in different bovine species in China and compare different test methods, a total of 1379 serum samples from clinical healthy dairy cattle, beef cattle, yaks (Bos grunniens), and water buffalo (Bubalus bubalis) were collected in eight provinces of China from 2010 to 2013. The samples were analyzed using commercial antibody (Ab) and antigen (Ag) detection kits, and RT-PCR based on the 5'-UTR and Npro gene sequencing. Results showed that the overall positive rates for BVDV Ab, Ag and RT-PCR detection were 58.09% (801/1379), 1.39% (14/1010), and 22.64% (146/645), respectively, while the individual positive rates varied among regions, species, and farms. The average Ab-positive rates for dairy cattle, beef cattle, yaks, and water buffalo were 89.49% (298/333), 63.27% (248/392), 45.38% (236/520), and 14.18% (19/134), respectively, while the Ag-positive rates were 0.00% (0/116), 0.77% (3/392), 0.82% (3/368), and 5.97% (8/134), respectively, and the nucleic acid-positive rates detected by RT-PCR were 32.06% (42/131), 13.00% (26/200), 28.89% (52/180), and 19.40% (26/134), respectively. In addition, the RT-PCR products were sequenced and 124 5'-UTR sequences were obtained. Phylogenetic analysis of the 5'-UTR sequences indicated that all of the 124 BVDV-positive samples were BVDV-1 and subtyped into either BVDV-1b (33.06%), BVDV-1m (49.19%), or a new cluster, designated as BVDV-1u (17.74%). Phylogenetic analysis based on Npro sequences confirmed this novel subtype. In conclusion, this study revealed the prevalence of BVDV-1 in bovine species in China and the dominant subtypes. The high proportion of bovines with detectable viral nucleic acids in the sera, even in the presence of high Ab levels, revealed a serious threat to bovine health.

Bovine viral diarrhea (BVD) is caused by the BVD virus (BVDV) and has been reported worldwide in cattle. To estimate BVDV circulation among cattle where few BVD cases were reported in southern Japan, 1910 serum samples collected from 35 cattle farms without a BVD outbreak were investigated to detect antibodies against BVDV-1 and BVDV-2 using an indicator virus with a cytopathogenic effect and the luciferase gene, respectively. Neutralizing antibodies against BVDV-1 and BVDV-2 were detected more frequently in 18 vaccinated farms than in 17 nonvaccinated farms. In the nonvaccinated farms, 9.6%, 1.8%, and 13.8% of the cattle were estimated to have a history of infection with BVDV-1, BVDV-2, and both, respectively. The median rate of within-herd anti-BVDV-1 seropositivity among cattle in the nonvaccinated farms was 22.0%; however, a high within-herd seropositivity (>50%) was confirmed in the two farms. The force of infection, basic reproduction number, and annual probability of BVDV-1 infection were estimated as 0.072 (95% confidence interval [CI]: 0.062–0.084), 0.36 (95% CI: 0.31–0.42), and 0.73% (95% CI: 0.61–0.87%), respectively, using the age-specific positive rate of anti-BVDV-1 antibodies. These parameters should be further applicable for developing epidemiological models which illustrate the BVDV dynamics in the field.

Bovine viral diarrhea (BVD) is a highly infectious disease affecting cattle, leading to significant economic losses in many countries engaged in cattle production. From February 2022 to October 2022, a study was conducted to determine the seroprevalence and associated risk factors of Bovine Viral Diarrhea Virus (BVDV) in the Sebeta subcity area of Sheger city, Ethiopia. The study utilized a semi-structured questionnaire to gather information on herd management practices from dairy farm owners. Serum samples from 170 individual cattle across 34 herds were collected and tested for BVDV antibodies using the indirect enzyme-linked immunosorbent assay (ELISA). The prevalence of BVD antibodies at both the animal and herd levels was analyzed, and potential risk factors were identified using Chi-square analysis and logistic regression. The study found that 19.41% of individual cattle (33 out of 170) and 44.12% of herds were positive for BVDV antibodies. Multiple logistic regression analysis identified several significant risk factors associated with BVDV infection. Multiparous dairy cows were found to be 2.3 times more likely to be seropositive compared to primiparous and nulliparous cows. Crossbreed dairy cattle had double the odds of being seropositive compared to pure breeds. Additionally, cattle from larger herds were 5.01 times more likely to be seropositive than those from smaller herds. Farms that introduced new animals had triple the odds of seropositivity compared to those that did not. The study indicates a high exposure rate of cattle to BVDV infection in and around Sebeta sub-city. Further research is recommended to explore the molecular epidemiology of BVDV in the region.

Bovine Viral Diarrhea Virus (BVDV) is a globally important cattle pathogen causing substantial economic losses. In Kazakhstan, BVDV’s epidemiological status remains poorly characterized due to the absence of systematic surveillance. We carried out a cross-sectional study of cattle herds across Kazakhstan, using ELISA to detect anti-BVDV antibodies and RT-PCR to identify active infections. Positive samples underwent sequencing for phylogenetic analysis of circulating strains. Additionally, a standard reference serum panel was developed to measure virus neutralization titers (ND50) and to evaluate cross-neutralization with Border Disease virus (BDV). Antibodies against BVDV were prevalent, with seropositivity ranging from 28.89% to 96.13% across surveyed regions. Active BVDV infection was confirmed by RT-PCR in 17 animals. Phylogenetic analysis with 2 samples from Mangystau region classified the virus as BVDV2 genotype. The reference serum panel exhibited high neutralizing titers ND50 up to 1:286 against the local BVDV-1 isolate. Notably, these sera also neutralized BDV, albeit at lower titers ND50 1:45. These findings provide crucial baseline epidemiological data and enhanced diagnostic tools for BVDV in Kazakhstan. They highlight the need for improved surveillance and will inform strategic control measures against this economically significant cattle disease.

In China, yaks are predominantly distributed across the Qinghai-Tibet Plateau and surrounding high-altitude regions, including Tibet, Qinghai, Sichuan, Gansu, Xinjiang and Yunnan. These animals serve as multifunctional resources for local herders, providing meat, dairy, hides, and wool, while also constituting a critical component of the industrial chain in high-altitude ecosystems. Recent epidemiological studies have demonstrated an increasing trend in bovine viral diarrhea virus (BVDV) infection rates among yak populations in provinces such as Gansu, Sichuan, Tibet, and Qinghai. This review not only summarizes the epidemiological status, distribution of viral sub-genotypes, and current prevention and control in yaks across various regions, but also proposes, for the first time, a systematic “Five-dimensional Integration” comprehensive prevention and control model for BVDV, including vaccine breakthrough, precise monitoring, dynamic early warning, population purification, and active prevention, which will provide directed insight for the prevention and control strategies of yaks infected by BVDV.

Bovine viral diarrhea virus (BVDV) is an important pathogen in cattle and causes considerable economic losses worldwide. In Argentina, where there is no national control program, BVDV remains endemic. In this retrospective study, the epidemiological, clinical and pathological features of postnatal BVDV-associated diseases in 50 outbreaks in central Argentina (1995–2024) were analyzed. Data were obtained from field reports, necropsies, and virological results (virus isolation, RT-nPCR, immunochromatography). No seasonal pattern was found. Acute infections (AIs) and mucosal disease (MD) occurred with similar frequency. Clinical signs included salivation, weakness, emaciation and diarrhea. The lesions were widespread and involved the gastrointestinal tract, skin, lymphoid tissues and spleen. Although MD cases has more extensive tissue involvement, no significant differences in morbidity, mortality or distribution of lesions were observed between AIs and MD. BVDV-1b was the most frequently detected subtype. These results highlight the challenges of BVDV control in extensive production systems. Strengthening diagnostic surveillance, implementing targeted vaccination and eliminating persistently infected animals are essential to reduce BVDV impact in endemic regions such as Argentina.

Bovine viral diarrhea virus (BVDV) is one of the major pathogens hindering the development of the global beef industry. To investigate the epidemic profile and genetic diversity of this virus, a total of 77 fecal samples were collected from cattle with diarrhea in Henan, Sichuan, Shandong, and Hebei provinces of China during 2023–2024 and screened for the presence of BVDV using reverse transcription polymerase chain reaction (RT-PCR). The results showed that 35 of the 77 bovine samples (45%) were positive for BVDV, with the highest positive rate of 26% (20/77) in Henan province. The 5ʹ-UTR sequences of the viruses from 21 positive samples and the whole-genome sequence from one sample (BVDV-385) were determined and analyzed. The 5ʹ-UTR sequences from this study were 74.7–96.4% identical to those of 23 reference sequences. Phylogenetic analysis based on the 5ʹ-UTR sequences indicated that 20 of the strains belonged to the subtype BVDV-1m, while only one, BVDV-385 from Henan province, belonged to genotype BVDV-3. Analysis of the genome sequence of strain BVDV-385 showed that its E2 protein has a unique amino acid (aa) deletion and ten unique aa substitutions, and its NS5B protein has seven unique aa substitutions. The variations were predicted to affect four potential linear B cell epitopes in the E2 protein and to introduce a potential non-canonical N-glycosylation site (574 NPS) in the NS5B protein. The results of this study contribute to our understanding of the genetic diversity of BVDV in China.